- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00461357
Sirolimus Based Immunosuppression for Patients Undergoing Kidney Transplantation in the Eurotransplant Senior Program (ESP)
Outcome After Renal Transplantation of a Randomized Prospective Trial in the Eurotransplant Senior Program
The Eurotransplant Senior Program (ESP) started in 1999 with local allocation of kidneys from deceased donors elder than 65 years to recipients elder than 65 years. The requirements for immunosuppression in this group of patients are high due to the large amount of comorbidities.
This prospective randomized trial compared the standard immunosuppressive protocol based on cyclosporine A (CyA) used at our center within the ESP, to a calcineurin inhibitor-free protocol based on sirolimus (SRL).
The aim of this study is to investigate the effect of a CNI-free therapy on the function of elderly kidneys 6 months post transplantation, measured by GFR.
Study Overview
Status
Study Type
Enrollment
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Recipients of the Eurotransplant Senior Program
- negative cytotoxic crossmatch
- signed informed consent
Exclusion Criteria:
- High sensitized recipients (PRA > 40%)
- Non heart Beating Donor
- Hyperlipidemia
- Leucocytopenia (< 3000/mm3)
- Thrombocytopenia (< 75000/mm3)
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ferdinand Muehlbacher, MD Professor, Medical University of Vienna; Department of Transplantation
Study record dates
Study Major Dates
Study Start
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- NTX-OFO-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Function After Transplantation
-
Gertrude J. Nieuwenhuijs-MoekeUnknownDelayed Graft Function | Renal Outcome After Kidney TransplantationDenmark, Netherlands, Spain
-
Technical University of MunichCompleted
-
Astellas Pharma IncCompletedthe Maintenance Phase After Kidney TransplantationJapan
-
Samsung Medical CenterCompletedDeceased Donor Kidney Transplantation | Living Donor Kidney TransplantationKorea, Republic of
-
University Hospital Inselspital, BerneCompletedKidney Transplantation | Delayed Graft FunctionGermany, Switzerland
-
Mayo ClinicRoche Pharma AGTerminatedKidney Transplantation | Delayed Graft FunctionUnited States
-
NovartisCompletedPrevention of Acute Rejection After Kidney Transplantation
-
NovartisCompletedPrevention of Acute Rejection After Kidney Transplantation
-
Yonsei UniversityUnknownKidney TransplantationKorea, Republic of
-
Nantes University HospitalTerminated